NEW THERAPIES FOR CUTANEOUS T-CELL LYMPHOMA

被引:6
作者
HEALD, PW
EDELSON, RL
机构
关键词
D O I
10.1001/archderm.123.2.189
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
引用
收藏
页码:189 / 191
页数:3
相关论文
共 18 条
[1]  
ACUTO O, 1985, NEW ENGL J MED, V312, P1100
[2]   SEZARY SYNDROME - MALIGNANT PROLIFERATION OF HELPER T CELLS [J].
BRODER, S ;
EDELSON, RL ;
LUTZNER, MA ;
NELSON, DL ;
MACDERMOTT, RP ;
DURM, ME ;
GOLDMAN, CK ;
MEADE, BD ;
WALDMANN, TA .
JOURNAL OF CLINICAL INVESTIGATION, 1976, 58 (06) :1297-1306
[3]   THERAPY OF CHRONIC LYMPHOCYTIC-LEUKEMIA AND CUTANEOUS T-CELL LYMPHOMA WITH T101 MONOCLONAL-ANTIBODY [J].
DILLMAN, RO ;
SHAWLER, DL ;
DILLMAN, JB ;
ROYSTON, I .
JOURNAL OF CLINICAL ONCOLOGY, 1984, 2 (08) :881-891
[4]  
ECCLES SA, 1985, CANCER IMMUNOL IMMUN, V19, P115
[5]  
HAYNES BF, 1982, J INVEST DERMATOL, V78, P323, DOI 10.1111/1523-1747.ep12507406
[6]  
KESSLER JF, 1983, LANCET, V1, P1345
[7]   ISOTRETINOIN AND CUTANEOUS HELPER T-CELL LYMPHOMA (MYCOSIS-FUNGOIDES) [J].
KESSLER, JF ;
JONES, SE ;
LEVINE, N ;
LYNCH, PJ ;
BOOTH, AR ;
MEYSKENS, FL .
ARCHIVES OF DERMATOLOGY, 1987, 123 (02) :201-204
[8]   KERATINOCYTE-DERIVED T-CELL GROWTH-FACTOR - A T-CELL GROWTH-FACTOR FUNCTIONALLY DISTINCT FROM INTERLEUKIN-2 [J].
KUPPER, TS ;
COLEMAN, DL ;
MCGUIRE, J ;
GOLDMINZ, D ;
HOROWITZ, MC .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1986, 83 (12) :4451-4455
[9]  
KUPPER TS, J EXP MED
[10]  
MILLER RA, 1983, BLOOD, V62, P988